Henri Beaufour
$2.97B
as of 10/04/24
About Henri Beaufour
Henri Beaufour owes his fortune to his stake in Ipsen, a French pharmaceutical giant that sells more than 25 drugs in 115 countries.
Founded in 1929 by grandfather Henri Beaufour, the family's 76% share of Ipsen was split between 3 siblings when father Albert Beaufour died in 2000.
Henri and his sister Anne now control about 52% of Ipsen, which generated 2022 revenues of more than $3.4 billion.
Sister Veronica sold her 6% stake.
Henri holds a bachelor's degree from Georgetown University, where he remains a prominent donor.
Personal stats
Citizenship
FranceSource of wealth
PharmaceuticalsResidence
London, United KingdomMarital status
MarriedBirth date
06/01/65 (age 59)Self-made
inheritedHenri Beaufour’s fortune is worth
49K
troy ounces of gold
46K
median U.S. household
30K
median U.S. income
0.059%
U.S. credit card volume
0.012%
GDP of the United States
0.009%
United States debt
Net worth history
Annual ranking
Net worth over time
Real-time ranking
Financial assets
EURONEXT PARIS | IPN-FR
Ipsen SAImages © Forbes.com. All rights reserved.